Validation dataset of 298 ER-positive patients treated with tamoxifen for 5 years. All patients in this dataset have ER+ breast cancer and were uniformly treated with tamoxifen for 5 years. The objec
PARP inhibitors can be used to treat solid tumors that often have mutations in important homologous recombination (HR) genes, such as BRCA1/2. While other kinds of tumors could also experience HR defi
AMI, acute myocardial infarction; PE, pulmonary embolism; IS, ischemic stroke; Combined score, the combination of miR-21-5p, miR-361-5p and miR-519e-5p; AUC, area under the ROC curve; 95% Cl, 95% conf
IV-tPA: intravenous thrombolysis; M1: M1 segment of the middle cerebral artery. Any proximal M1 occlusion on admission MR Angiography was considered, irrespective of the status of other arteries.mRS:
